Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry		 vs
history
Cash-to-Debt 1.03
APEN's Cash-to-Debt is ranked lower than
66% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. APEN: 1.03 )
Ranked among companies with meaningful Cash-to-Debt only.
APEN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.16  Med: No Debt Max: No Debt
Current: 1.03
0.16
No Debt
Equity-to-Asset 0.50
APEN's Equity-to-Asset is ranked lower than
75% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. APEN: 0.50 )
Ranked among companies with meaningful Equity-to-Asset only.
APEN' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.27  Med: 0.5 Max: 1
Current: 0.5
-1.27
1
Debt-to-Equity 0.60
APEN's Debt-to-Equity is ranked lower than
76% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 0.30 vs. APEN: 0.60 )
Ranked among companies with meaningful Debt-to-Equity only.
APEN' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.52  Med: 0.01 Max: 1.18
Current: 0.6
-0.52
1.18
Debt-to-EBITDA -2.11
APEN's Debt-to-EBITDA is ranked lower than
99.99% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. APEN: -2.11 )
Ranked among companies with meaningful Debt-to-EBITDA only.
APEN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.1  Med: -2.62 Max: 0.01
Current: -2.11
-8.1
0.01
Piotroski F-Score: 4
Altman Z-Score: -0.48
Beneish M-Score: -2.81
WACC vs ROIC
6.22%
-47.13%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry		 vs
history
Operating Margin % -39.41
APEN's Operating Margin % is ranked lower than
71% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. APEN: -39.41 )
Ranked among companies with meaningful Operating Margin % only.
APEN' s Operating Margin % Range Over the Past 10 Years
Min: -410.17  Med: -48.41 Max: 15.13
Current: -39.41
-410.17
15.13
Net Margin % -46.55
APEN's Net Margin % is ranked lower than
72% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. APEN: -46.55 )
Ranked among companies with meaningful Net Margin % only.
APEN' s Net Margin % Range Over the Past 10 Years
Min: -400.56  Med: -50.59 Max: 33.45
Current: -46.55
-400.56
33.45
ROE % -64.39
APEN's ROE % is ranked lower than
81% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. APEN: -64.39 )
Ranked among companies with meaningful ROE % only.
APEN' s ROE % Range Over the Past 10 Years
Min: -231.4  Med: -93.77 Max: 146.27
Current: -64.39
-231.4
146.27
ROA % -28.72
APEN's ROA % is ranked lower than
71% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. APEN: -28.72 )
Ranked among companies with meaningful ROA % only.
APEN' s ROA % Range Over the Past 10 Years
Min: -126.81  Med: -29.84 Max: 46.07
Current: -28.72
-126.81
46.07
ROC (Joel Greenblatt) % -264.06
APEN's ROC (Joel Greenblatt) % is ranked lower than
76% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. APEN: -264.06 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
APEN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -8243.06  Med: -252.55 Max: 687.79
Current: -264.06
-8243.06
687.79
3-Year Revenue Growth Rate -41.50
APEN's 3-Year Revenue Growth Rate is ranked lower than
93% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. APEN: -41.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
APEN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -41.5  Med: 9.95 Max: 145.1
Current: -41.5
-41.5
145.1
3-Year EBITDA Growth Rate 77.50
APEN's 3-Year EBITDA Growth Rate is ranked higher than
97% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. APEN: 77.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
APEN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 6.65 Max: 77.5
Current: 77.5
0
77.5
3-Year EPS without NRI Growth Rate 70.30
APEN's 3-Year EPS without NRI Growth Rate is ranked higher than
95% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 7.80 vs. APEN: 70.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
APEN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -18.3 Max: 70.3
Current: 70.3
0
70.3
GuruFocus has detected 2 Warning Signs with Apollo Endosurgery Inc APEN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» APEN's 30-Y Financials

Financials (Next Earnings Date: 2018-10-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income
» APEN's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades

APEN Guru Trades in

Q4 2017

APEN Guru Trades in Q4 2017

Jim Simons 22,500 sh (New)
» More
Q1 2018

APEN Guru Trades in Q1 2018

Jim Simons 34,600 sh (+53.78%)
» More
Q2 2018

APEN Guru Trades in Q2 2018

Jim Simons 45,300 sh (+30.92%)
» More
» Details

Insider Trades

Financial Reports

Latest Guru Trades with APEN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3842
Compare:TSE:5187, OTCPK:ZYXI, NAS:MSON, NAS:EYES, OTCPK:BTCY, XKRX:056090, XKRX:208370, ROCO:4745, NAS:VIVE, XKRX:156100, LSE:IDH, LSE:BQE, XKRX:004080, OSTO:BACTI B, XPAR:MKEA, TSXV:VMD, XKRX:216280, OTCPK:IVOB, AMEX:XTNT, XKRX:059210 » details
Traded in other countries:HQ8F.Germany,
Headquarter Location:USA
Apollo Endosurgery Inc is a developer of medical devices in the United States. The company's major focus area is obesity and gastrointestinal diseases.

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focusses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include ORBERA, LAP-BAND and OverStitch.

Top Ranked Articles about Apollo Endosurgery Inc

Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo — Research Highlights Growth, Revenue, and Consolidated Results
August 16, 2018
Read more...
Weekly CFO Buys Highlight Recent buys from company CFOs
June 27, 2018
According to GuruFocus Insider Data, the recent CFO buys are: Aqua Metals Inc. (NASDAQ:AQMS), Apollo Endosurgery Inc. (NASDAQ:APEN), Red Violet Inc. (NASDAQ:RDVT). Read more...
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO Technologies, and Tilly's — Research Highlights Growth, Revenue, and Consolidated Results
March 30, 2018
Read more...
Market Trends Toward New Normal in Cornerstone Strategic Return Fund, Acacia Communications, PennantPark Floating Rate Capital, Floor & Decor, Liberty Media, and Apollo Endosurgery — Emerging Consolidated Expectations, Analyst Ratings
January 31, 2018
Read more...

Ratios

vs
industry		 vs
history
PB Ratio 2.71
APEN's PB Ratio is ranked higher than
64% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. APEN: 2.71 )
Ranked among companies with meaningful PB Ratio only.
APEN' s PB Ratio Range Over the Past 10 Years
Min: 0.35  Med: 5.63 Max: 116.89
Current: 2.71
0.35
116.89
PS Ratio 1.85
APEN's PS Ratio is ranked higher than
76% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. APEN: 1.85 )
Ranked among companies with meaningful PS Ratio only.
APEN' s PS Ratio Range Over the Past 10 Years
Min: 0.04  Med: 6.56 Max: 409.8
Current: 1.85
0.04
409.8
EV-to-EBIT -5.95
APEN's EV-to-EBIT is ranked lower than
99.99% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.76 vs. APEN: -5.95 )
Ranked among companies with meaningful EV-to-EBIT only.
APEN' s EV-to-EBIT Range Over the Past 10 Years
Min: -217.7  Med: -4.95 Max: 243.2
Current: -5.95
-217.7
243.2
EV-to-EBITDA -9.46
APEN's EV-to-EBITDA is ranked lower than
99.99% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 18.14 vs. APEN: -9.46 )
Ranked among companies with meaningful EV-to-EBITDA only.
APEN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -26.4  Med: -6.1 Max: 5194.6
Current: -9.46
-26.4
5194.6
EV-to-Revenue 2.35
APEN's EV-to-Revenue is ranked higher than
74% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 3.73 vs. APEN: 2.35 )
Ranked among companies with meaningful EV-to-Revenue only.
APEN' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.5  Med: 5.3 Max: 426.8
Current: 2.35
-2.5
426.8
Current Ratio 2.87
APEN's Current Ratio is ranked lower than
59% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. APEN: 2.87 )
Ranked among companies with meaningful Current Ratio only.
APEN' s Current Ratio Range Over the Past 10 Years
Min: 0.43  Med: 2.92 Max: 9.25
Current: 2.87
0.43
9.25
Quick Ratio 2.18
APEN's Quick Ratio is ranked lower than
57% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. APEN: 2.18 )
Ranked among companies with meaningful Quick Ratio only.
APEN' s Quick Ratio Range Over the Past 10 Years
Min: 0.43  Med: 2.92 Max: 9.25
Current: 2.18
0.43
9.25
Days Inventory 193.37
APEN's Days Inventory is ranked lower than
65% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 143.61 vs. APEN: 193.37 )
Ranked among companies with meaningful Days Inventory only.
APEN' s Days Inventory Range Over the Past 10 Years
Min: 113.83  Med: 180.34 Max: 196.82
Current: 193.37
113.83
196.82
Days Sales Outstanding 65.35
APEN's Days Sales Outstanding is ranked higher than
53% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 69.21 vs. APEN: 65.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
APEN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.45  Med: 57.93 Max: 716.86
Current: 65.35
10.45
716.86
Days Payable 201.34
APEN's Days Payable is ranked higher than
92% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. APEN: 201.34 )
Ranked among companies with meaningful Days Payable only.
APEN' s Days Payable Range Over the Past 10 Years
Min: 83.36  Med: 197.28 Max: 272.17
Current: 201.34
83.36
272.17

Buy Back

vs
industry		 vs
history
3-Year Average Share Buyback Ratio -310.50
APEN's 3-Year Average Share Buyback Ratio is ranked lower than
98% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. APEN: -310.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
APEN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -310.5  Med: -31 Max: -3.2
Current: -310.5
-310.5
-3.2

Valuation & Return

vs
industry		 vs
history
Price-to-Net-Current-Asset-Value 20.88
APEN's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 7.79 vs. APEN: 20.88 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
APEN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.56  Med: 9.73 Max: 649
Current: 20.88
0.56
649
Price-to-Tangible-Book 9.70
APEN's Price-to-Tangible-Book is ranked lower than
87% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. APEN: 9.70 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
APEN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.54  Med: 9.57 Max: 368.82
Current: 9.7
0.54
368.82
Price-to-Median-PS-Value 0.28
APEN's Price-to-Median-PS-Value is ranked higher than
96% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. APEN: 0.28 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
APEN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01  Med: 1.07 Max: 59.19
Current: 0.28
0.01
59.19
Earnings Yield (Greenblatt) % -16.89
APEN's Earnings Yield (Greenblatt) % is ranked lower than
83% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.74 vs. APEN: -16.89 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
APEN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -8845.9  Med: -15.15 Max: 3014.6
Current: -16.89
-8845.9
3014.6

More Statistics

Revenue (TTM) (Mil) $64.22
EPS (TTM) $ -1.71
Beta0.30
Volatility50.36%
52-Week Range $3.75 - 9.65
Shares Outstanding (Mil)21.88

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 64 68 74
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) -1.74 -1.15 -0.80
EPS without NRI ($) -1.74 -1.15 -0.80
EPS Growth Rate
(Future 3Y To 5Y Estimate)		 N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAN
Positive CFROAN
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for APEN

Headlines

Articles On GuruFocus.com
Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biother Aug 16 2018 
Weekly CFO Buys Highlight Jun 27 2018 
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurg Mar 30 2018 
Market Trends Toward New Normal in Cornerstone Strategic Return Fund, Acacia Communications, Pennant Jan 31 2018 
Weekly CFO Buys Highlight Jul 30 2017 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}